Trial Profile
Comparison of Rosiglitazone Versus Glyburide on Vascular Structure and Function in Type 2 Diabetic Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary) ; Glibenclamide
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 08 Aug 2012 Actual end date (1 Dec 2005) added as reported by ClinicalTrials.gov.
- 03 Dec 2005 New trial record.